Belgian molecular Dx company obtains $7.3 million

02/15/2013 | GenomeWeb Daily News (free registration)

A funding round has pulled in $7.3 million for Multiplicom, a Belgian firm that develops research-use-only test kits for muscle disease, cystic fibrosis, kidney disease, heart failure and bowel cancer. The company will use the money to further develop its molecular diagnostic tests and expand its sales channels in Europe.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ